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A  B  S  T  R  n C  T  Determinations have been made of the level of serotonin in various 
fetal and maternal tissues  of goats and rabbits.  In the goat,  both fetal brain 
and blood were higher in serotonin content than comparable maternal tissues. 
Furthermore, in  the goat fetal neocortical areas unexpectedly were found to 
be  richer in serotonin than  certain subcortical structures.  In contrast to the 
goat, the rabbit was shown to have higher serotonin levels in maternal than in 
fetal blood.  Moreover, when  a  large  amount of serotonin was  administered 
subcutaneously to pregnant rabbits,  the fetuses  began to die at a  time when 
the maternal  blood levels of serotonin had about doubled.  This toxic action 
was shown to be due at least partially to the sensitivity of the umbilical vessels 
to the vasoconstrictor action of serotonin. 
Except for a few isolated reports on endogenous 5-hydroxytryptamine (5-HT, 
serotonin) in fetal and early postpartum life  (1-3)  little is known about the 
occurrence and significance of this amine in the developing mammal. On the 
other hand, the toxic potentiality of 5-HT upon the developing fetus has been 
made clear.  It has  been reported that  5-HT administered to pregnant rats 
(4,  5)  and mice  (6,  6  a)  can interrupt pregnancy and  lead  to death of the 
fetuses. 
This paper has the double purpose of (a) presenting results on the content 
of 5-HT in several tissues of the fetuses of goats and rabbits and (b) of present- 
ing data on the interruption of pregnancy in the rabbit by 5-HT and  on a 
possible mechanism of this toxic action. 
METHODS 
Goat fetuses,  15 to 25 days before birth (gestation time,  145 to 150 days), were ob- 
tained  by  cesarean  section  from  goats  anesthetized  with  pentobarbital  sodium. 
Samples of maternal and fetal blood were withdrawn simultaneously before delivery. 
The mother goat was sacrificed shortly after delivery by an intracardiac injection of 
potassium chloride, while the kid was sacrificed by light chloroform anesthesia,  in 
both cases followed by exsanguination from the severed neck vessels. The maternal 
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and fetal tissues were stored in ice before extraction of 5-HT which was carried  out 
generally 15 to 30 minutes after sacrifice of the animals. 
Rabbits during  the  last third  of pregnancy  (gestation  time,  27  to  31  days)  were 
lightly  anesthetized  with  pentobarbital  sodium  and  cannulated  for  withdrawal  of 
blood.  In  three  experiments maternal  blood  pressure in  the  carotid  artery was re- 
corded by means of a Statham arterial pressure transducer and Gilson minipolygraph. 
The abdominal wall was opened along the midline and the uterus partially exposed. 
By a  short longitudinal  incision in the uterus and fetal membranes, the fetuses were 
exposed  without  interrupting  their  vascular  supply.  In  the  experiments  in  which 
the action of 5-HT on the umbilical vessels was studied,  the fetuses were maintained 
alive, out of the uterus, embedded in cotton moistened with warm saline. In this way 
the fetoplacental circulation was not interfered with and  the fetuses were kept in a 
viable condition  for a  period  of 20  minutes.  Special  care was  taken  to maintain  a 
constant temperature of 38°C  around  the fetuses. 
In all experiments,  blood from the  fetuses was obtained whenever possible from 
the umbilical vessels by means of a  27 gauge needle. When the fetuses were too small 
for this  procedure,  blood was obtained from the  severed neck vessels.  Immediately 
after withdrawal of the blood samples the umbilical vessels were severed and certain 
of the fetal tissues excised and extracted for 5-HT by the method of Amin et al.  (7). 
The  extracts  were  assayed  on  the  heart  of Mercenaria  (Venus)  mercenaria within  48 
hours. 
Monoamine  oxidase  activity  of the  placenta  was  determined  by  the  following 
procedure.  Placental  tissue  (0.25  to  0.5  gm)  was homogenized  in  10  volumes of a 
modified  McIlwain  medium  buffered  at  pH  7.4.  Serotonin  creatinine  sulfate  was 
added in amounts from 2 to 20 y  (of base) and the suspension incubated and shaken 
at 37°C. At the end of 1 hour the entire mixture was extracted and assayed for 5-HT 
as above. 
5-Hydroxytryptophan decarboxylase  activity was  determined  by  the  method  of 
Gaddum and Giarman  (8)  with the exception that the  5-HT was assayed as above 
instead of on the isolated rat's uterus. 
RESULTS  AND  DISCUSSION 
1.  Experiments with Goats  Table I  shows the levels of 5-HT found in the 
blood, in several parts of the brain,  and in the lungs of goat fetuses, and levels 
of 5-HT  from comparable  tissues from mother goats and from a  24 hour old 
kid. 
It appears that fetal blood in this species contains  1.5 times more 5-HT than 
maternal blood.  Furthermore,  the fetal brain is richer in  5-HT  than the ma- 
ternal  brain,  the  difference being more marked  in  the parietal  and  occipital 
lobes than in the hippocampus and basal ganglia.  This finding of 5-HT levels 
higher  in  cortical  than  in  subcortical  structures  of the fetal brain  was  unex- 
pected; but it may be seen that in the 24 hour old kid the relative distribution 
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adult brains of all species thus far studied). The level in the blood of the day 
old kid,  however, is still higher than  that found in the maternal  blood. 5-HT 
was also found in  appreciable quantities  in the placenta  and  allantoic  fluid, 
but was almost non-detectable in amniotic fluid. 
2.  Experiments with Rabbits  In contrast to the goat, it may be seen in the 
first two columns of Table II that in the rabbit the level of 5-HT in the ma- 
ternal blood is almost twice as high as that found in the fetal blood. It appears 
that this difference is greatest in early stages of fetal development and much 
less  at  the  end  of pregnancy  (this  may  be  observed  in  Table  II  in  which 
TABLE  I 
5-HT  DISTRIBUTION  IN  FETAL  AND 
MATERNAL TISSUES  OF  GOAT 
Fetus  Mother  24 hr old kid 
Mean 
Tissues  No.  5-HT  Range  No. 
Mean  Mean 
5-HT  Range  No.  5-HT 
3"lgm 
Blood, '7/ce  6  3.35*  (1.83-8.00) 
Brain 
Parietal lobe  5  0.36~  (0.10-0.93) 
Occipital lobe  5  0.29§  '  (0,16--0.46) 
Hippocampus  4  0.25  (0.16-0.44) 
Basal ganglia  5  0.27  (0.18-0.35) 
Pineal body 
Lungs  3  0.65  (0.11-1.1) 
Amniotic fluid  3  0.02  (0.006-0.03) 
Allantoic fluid  4  0.31  (0.12-0.40) 
Placenta  3  0.26  (0.25--0.27) 
3,/g~  "y/gm 
6  1.99"  (0.27-4.2)  1  6.2 
5  0.10$  (0.07-0.12)  1  0.18 
5  0,09§  (0.08-0.11)  1  0.22 
3  O. 15  (0.13-0.14)  1  O. 10 
5  0.17  (0.11-0.22)  1  0.45 
5  3.20  (1.20-7.00)  1  0,45 
3  1,56  (0.8-2.2)  1  0.93 
* The difference between these values is  statistically significant at  a  level of p  <  0.01  deter- 
mined in the manner described by "Student" and Fisher. 
~p  < 0.01. 
§p < o.ool. 
fetuses of light weight may be considered those of earlier development). 
Table  II summarizes  the effect of the subcutaneous injection of 5-HT  (10 
mg/kg)  into pregnant rabbits, on the level of 5-HT in the maternal  and fetal 
blood, and on the viability of the fetuses, 
The administration  of 5-HT is obviously followed by a  rise of 5-HT in the 
blood of both mother and fetus : the peak values were observed generally in 30 
minutes  in  both fetal  and  maternal  blood.  It  is  important  to  note  that  the 
administration  of  5-HT  under  these  conditions  caused  no  changes  in  the 
maternal  arterial  pressure  recorded  from  the  carotid  artery.  In  all  experi- 
ments,  1 hour after the administration  of 5-HT all fetuses were dead and the 
placentas showed a marked change in color from bright to dark red. It may be 578  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  45  "  Z96':' 
TABLE  II 
CHANGES  OF  5-HT  LEVEL  IN  MATERNAL 
AND  FETAL  5-HT  AFTER  ADMINISTRATION  OF  5-HT 
TO  THE  MOTHER  RABBIT 
Time, rain.  ---30  0  30  60  70  90  120 
5-HT in maternal (M.B.) and fetal blood (F.B.) 
Fetal weight  Dose  Dose 
(range)  M.B.  F.B.  5-HT*  M.B.  F.B.  M.B.  F.B.  5-HT*  M.B.  F.B.  M.B.  F,B. 
gm  'T/co  q,']oo  mg/kg  "),/co  T/ca  "),1~  T#O  mg/kg  'y/co  "[/¢~ 
5.9-6.3  1.31  0.62  0  1.57  0.62  1.31  0.62  0  1,57 
13.4-16.2  2.25  1.2  0  2.25  1.2  2.25  0.9  0  2.4  1.1 
"r/cc  "rico 
6.0-6.5  1.5  0.53  10  2.2  1.66  2.9  0.8~:  0  2.62  2.05 
7.0-9.7  1.2  0.6  I0  3.62  1.0  2.25  0.4~:  10  4.12  0.35 
14.1-17.5  2.5  2.0  10  2.0  1.33  3.0  1.1:~  0  2.4  1.1  1.4  2.5 
17.5-21.9  1.38  1.5  10  2.22  2.8  3.0  0,2:~  10  3.5  0.95  2.62  1.2 
39.5-57.1  1.93  1.5  10  4.5  2.6~  3.7  0,55  0 
Mean  1.72§  1.13  2.91  1.88 
* Mg/kg,  subcutaneously. 
Dead fetuses. 
§ The  difference between these two means is statistically significant  (p  <  0.001)  by  the  t  test 
of significance described  by  "Student"  and Fisher. 
TABLE  III 
RABBIT:  5-HT  CONTENT  OF  FETAL  BRAIN  AND  FETAL 
INTERNAL  ORGANS  BEFORE  AND  AFTER  THE  INJECTION  OF  5-HT 
(10 MG/KG,  SUBCUTANEOUSLY)  TO  THE  MOTHER 
Time, min.  --30  0 
5-HT level 
Fetal weight  Other 
range  Brain  tissues  5-HT 
~  6o  ~ 
5-HT level 
Other  Other 
Brain  tissues  Brain  tissues 
7]gm  ?lgra  mg/kg  "y/gm  ,y/gra 
5.9-6.3  0.05  0.15  Saline  0.25  0.17  0.11  0.3 
13.4-16.2  0.20  0.6  Saline  --  --  --  0.63 
6.0-6.5  0.09  0.13  10  0,09  0.12  0.11"  0.2 
14.1-17.5  0.14  0.21  10  0,12  0.87  0.11"  2.5 
39.9-57.1  0.19  --  10  0.13"  --  0.13"  -- 
7.0-9.7  --  0.16  10  --  0.10  --*  0.1 
17.5-21.9  --  0.6  10  --  1.23  --*  2.2 
Mean  values  0.13  0.31~  0.11  0.585  0.12  1.3 
* Dead fetuses. 
J~ The  difference  between  these  two  values  is  not  statistically  significant  as  determined  by 
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observed that death  of the fetuses occurred when the 5-HT level in maternal 
Mood had almost doubled. In one experiment the level had more than doubled 
in 30 minutes and  the fetus died in this case in a  shorter period of time. 
The  5-HT  content  of the fetal  blood  30  minutes  after  5-HT  rose propor- 
tionally as high as that of the maternal  blood. This increase is,  therefore,  evi- 
dence  that  5-HT  in  the  maternal  circulation  can  traverse  the  placental 
barrier. A net decrease in 5-HT was observed in the blood of the fetuses which 
died 60 minutes after the administration  of 5-HT to the mother. 
During the course of these experiments,  at a  time  when the fetal blood was 
obtained for determination  of 5-HT, the fetus was sacrificed and its brain and 
pooled  internal  organs  (lungs,  spleen,  and  entire  gastroenteric  tract)  were 
analyzed  for  5-HT  content.  Table  III  summarizes  these  results.  It  may  be 
seen that  while the administration  of 5-HT  to the pregnant  mother  led  to a 
variable increase in the pooled internal  organs of the fetus within 60 minutes, 
such administration failed to cause any increase in 5-HT content of fetal brain. 
This  finding  suggests  that  a  blood-brain  barrier  toward  5-HT  is  already 
formed in fetal life, even  in early stages of development. 
Careful  observation  of the fetuses after  the administration  of 5-HT to  the 
mother  revealed  a  gradual  and  powerful  vasoconstriction  of the  umbilical 
vessels.  In order to investigate any inordinate  sensitivity of the umbilical  ves- 
sels to  5-HT,  5 3'  of 5-HT  in 0.5 ml  of saline  solution was  injected  directly 
into the small vessels forming the umbilical vein.  Fig.  1A shows the fetal ves- 
sels  immediately  before the  injection,  and  Fig.  1B  clearly  demonstrates  the 
vasoconstriction caused by the injection of 5-HT.  Fig.  1C is the control show- 
ing that the injection of 0.5 ml of isotonic saline solution did not constrict the 
vessels but caused only a  small  hemorrhage  at  the injection  point.  It was of 
interest to find that the injection of the same amount of 5-HT into one of the 
omental  vessels  of  a  pregnant  rabbit  caused  no  vasoconstriction,  but  did 
greatly  increase  intestinal  motility. 
Recently, Waugh and Pearl (5) have reported that the interruption  of preg- 
nancy in rats brought about by the administration  of 5-HT is associated with 
renal lesions of ischemic origin analogous to those reported previously by sev- 
eral  investigators  (9-12).  Histological  examination  of the  kidneys  obtained 
from the rabbits  at  the end of our experiments  in  which 5-HT had  been ad- 
ministered showed extensive glomerular damage with lymphocytic infiltration. 
3.  5-Hydroxvlryptophan  Decarboxylase  and  Monoamine  Oxidase  Activity  To 
what  extent  the fetal tissues form  and  destroy the  5-HT present  in  the fetus 
are still  unanswered  questions.  It has  been demonstrated  that  fetal  tissues of 
the rat  and  ot the  human  being form large  amounts  of histamine  (13).  The 
kidneys of rat fetuses have also been shown to be rich in 5-hydroxytryptophan 
(5-HTP)  decarboxylase activity  (14). 580  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  45  "  I96~ 
In this work we have found 5-HTP decarboxylase activity in several parts 
of the fetal brain of the goat.  In addition it was observed that the placenta of 
both  goat  and  rabbit  produce  5-HT  from  5-HTP.  Table  IV  summarizes 
these data. 
Placentas  of the human being, rat, rabbit, and guinea pig have been shown 
to possess  monoamine oxidase  (MAO)  activity  (15).  In  this work  MAO  ac- 
tivity was  also found in the placenta  of the goat. 
FIGURE 1A.  Umbilical vein of the rabbit before injection of serotonin. 
FIGURE lB.  Vasoconstriction  of the umbilical  vein of the rabbit immediately following 
injection of serotonin (5 "y in 0.5 ml saline). G. PEPEU AND N. J. GIARMAN  Serotonin  in Developing  Mammal  58x 
FIGURE  1C.  Umbilical vein  of the  rabbit  immediately following injection of physi- 
ological  saline  solution  (0.5  ml). 
GENERAL  DISCUSSION 
On the basis of experiments  in  the rat  and  guinea  pig,  Karki  et al.  (3)  sug- 
gested  a  correlation  between the level  of brain  5-HT at birth  and  extent  of 
development of the newborn.  They found,  in fact,  that  the relatively imma- 
ture fetus or newborn  of the rat  had  a  relatively low level of cerebral  5-HT, 
while the more advanced fetus or newborn of the guinea pig had  a  level al- 
most as high as in the adult.  Goat fetuses at  15 to 25 days before birth are cer- 
tainly well advanced,  even though only few can survive if delivered out of the 
uterus at this stage of development.  This fact, in the light of the suggestion of 
Karki and Brodie, might correlate with a  brain level of 5-HT as high as that 
in the adult,  but the significance of fetal levels higher than those of the adult, 
TABLE  IV 
RELATIVE  5-HTP  DECARBOXYLASE 
ACTIVITY  IN  FETAL  AND  ADULT  TISSUES 
OF  GOAT  AND  RABBIT 
5-HTP decarboxylase  activity* in 
Species  Tissue  Fetus  Mother 
Goat  Parietal cortex  0,7  1.0 
Diencephalon  3.8  10.0 
Placenta  6.0 
Rabbit  Placenta  3.0 
* Relative to activity of maternal parietal cortex as 1 (i.e.,  conversion of 440 3'- 5-HTP to 15 3" 
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found in our work,  is obscure.  Equally difficult to explain is  the presence of 
higher amounts of 5-HT in fetal neocortical structures than those found in the 
hippocampus or basal ganglia. This type of distribution of 5-HT in the fetal 
brain  is  in  sharp  contrast  to  that found in  adult  goats,  in  fetal  and  adult 
rabbits, in human adults (16), and in adult dogs (17).  On the other hand, the 
5-HT levels found in the brain of the rabbit fetus compared  to those of the 
adult showed essentially the same pattern described by Karki and Brodie for 
the rat,  and it is interesting in this context to note the rather  poor develop- 
ment of newborn rabbits,  similar to newborn  rats.  One consideration to be 
taken into account here is the role pentobarbital anesthesia may play in the 
levels of 5-HT found in fetal brains. The fact that barbiturates cause an eleva- 
tion in brain 5-HT is amply documented (18,  19). This coupled with the find- 
ing that barbiturates are more slowly degraded in tissues of the newborn (20) 
and are concentrated by the fetal brain stem  (21)  might explain the greater 
level of 5-HT in fetal brains found in the goat. On the other hand, the rabbits 
in  this  study were  also  anesthetized  with  pentobarbital  and  fetal  levels  of 
5-HT in this species are not higher than maternal levels. 
Relatively large amounts of 5-HT were found in fetal blood and tissues of 
the rabbit.  This fact, in addition to the findings that even larger amounts of 
5-HT are present in the maternal blood and that the amine is actively formed 
by the placenta would seem to conflict with the observation that modest in- 
creases in circulating levels of the amine can interrupt pregnancy in the rabbit 
and cause death of the fetuses. Death of the fetuses in these studies occurred 
when the level of 5-HT in the maternal blood had just about doubled, follow- 
ing subcutaneous administration of the amine. To be sure, the dose of 10 mg/kg 
used here is a  large one, but it is much lower than the subcutaneous LDs0 in 
the rat which has been calculated to be  117 mg/kg (22). 
Apparently, much of the toxic action upon the fetus of high circulating 5-HT 
in the maternal blood may be attributed to the sensitivity of umbilical vessels 
to the vasoconstrictor action of the amine.  Such sensitivity has been demon- 
strated clearly in this work, as well as in the studies of Astrom and  Samelius 
(23)  on isolated human umbilical vessels,  and  in the more recent studies  of 
Goerke et  al,  (24)  on isolated perfused human placenta.  It is somewhat sur- 
prising that death of the fetus usually supervened when the maternal circulat- 
ing level of 5-HT had about doubled, in view of the fact that one can  induce 
three- to fivefold increases in 5-HT in tissues of non-pregnant animals without 
any apparently adverse  effects.  These  findings in  conjunction with  the  ex- 
tensive kidney lesions found in  pregnant  rabbits  treated  with  5-HT  might 
prompt further investigation of a  possible role of 5-HT in eclampsia. 
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